Skip to main content
Search hero banner

Search results

Showing 121 - 140 of 249 results

Doctors viewing a SPECT scan

Radionuclides in medicine

Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs to diagnose or treat disease.

For three unknown medical radionuclides, students will graph their decay over time, use the graph to calculate their half-life, and determine the identify and use of each radionuclide using background information provided.

Chronic Kidney disease of unknown origin

Chronic kidney disease of unknown origin

In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).

business-services-health-ansto

Nuclear Medicine

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

Cryogenic Permanent Magnet Undulator (CPMU) source for the BRIGHT Nanoprobe beamline

Nanoprobe beamline (NANO) - under construction

The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.

Mo-99 Manufacturing Facility

Mo-99 Manufacturing Facility

ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.

Imaging radiation

Gamma radiation imaging technology

A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.

Pagination